Picard Medical (PMI) Common Equity (2024 - 2026)

Picard Medical has reported Common Equity for 3 years, with the latest figure at -$1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 97.04% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$1.4 million (up 97.04% YoY), and the FY2025 full-year result was $3.8 million, up 108.61% from the prior year.
• Common Equity for Q1 2026 stood at -$1.4 million, down from $3.8 million in the prior quarter.
• The five-year high for Common Equity was $8.0 million in Q3 2025, with the low at -$54.5 million in Q2 2025.
• Historically, Common Equity has averaged -$25.3 million across 3 years, with a median of -$32.5 million in 2024.
• The largest YoY upside for Common Equity was 122.51% in 2025 against a maximum downside of 83.88% in 2025.
• Picard Medical's Common Equity stood at -$44.0 million in 2024, then jumped by 108.61% to $3.8 million in 2025, then plunged by 138.22% to -$1.4 million in 2026.
• The last three Common Equity figures came in at -$1.4 million (Q1 2026), $3.8 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.